AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. CNSP
  4. [8-K] CNS Pharmaceuticals, Inc. Reports Material Event

[8-K] CNS Pharmaceuticals, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Filing content is currently unavailable.

Source:

Stock CNSP logo
CNS Pharmaceuticals

NASDAQ:CNSP

CNSP Rankings

#6386 Ranked by Market Cap
N/A Ranked by Dividends
#53 Top Loser

CNSP Latest News

Aug 14, 2025
CNS Pharmaceuticals to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
Jul 22, 2025
CNS Pharmaceuticals to Participate in the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference
Jul 18, 2025
CNS Pharmaceuticals Announces Reverse Stock Split
Jul 9, 2025
CNS Pharmaceuticals Participates in Virtual Investor CEO Connect Segment
Jun 24, 2025
CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment Discussing Glioblastoma Multiforme (GBM) and Lead Product Candidate TPI 287

CNSP Latest SEC Filings

Jul 15, 2025
[8-K] CNS Pharmaceuticals, Inc. Reports Material Event

CNSP Stock Data

3.51M
454.19k
0.21%
0.97%
6.86%
Biotechnology
Pharmaceutical Preparations
United States
HOUSTON